However, over the next year, initiation slowed and even reversed: with first-time prescribing rates declining 31% by June 2025, reflecting an average month-over-month decrease of 0.004 percentage points
Compounders can step in to fill the gap
Recalls & Warnings June 21, 2005 FTC Settles Claims with Marketers of FiberThin and Propolene On June 20, 2005, the Federal Trade Commission (FTC) announced that the marketers of the dietary supplements FiberThin and Propolene have settled FTC charges that their misleading weight-loss claims violated federal laws
Results vary, but the average patient can expect to start moving toward a healthier weight within weeks
Originally developed to manage type 2 diabetes, Semaglutide also helps stabilize blood sugar levels and improve insulin sensitivity
The list price for Zepbound is $1,086.37